This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Predictors of response to erlotinib in patients with advanced NSCLC. Nat Rev Clin Oncol 5, 684–685 (2008). https://doi.org/10.1038/ncponc1246
Issue Date:
DOI: https://doi.org/10.1038/ncponc1246
- Springer Nature Limited